Add Company
Join Now

Deka BioSciences Revenue and Competitors

License our Company Data API

Rockville,

Location

#2110

Growjo Ranking

Biotech

Industry
Embed

Estimated Revenue & Valuation

  • Deka BioSciences's estimated annual revenue is currently $8.1M per year.(i)
  • Deka BioSciences's estimated revenue per employee is $155,000

Employee Data

  • Deka BioSciences has 52 Employees.(i)
  • Deka BioSciences grew their employee count by 30% last year.

Deka BioSciences's People

NameTitleEmail/Phone
1
Co-founder & CBOReveal Email/Phone
2
VP Technical OperationsReveal Email/Phone
3
VP, Clinical OperationsReveal Email/Phone
4
General CounselReveal Email/Phone
5
Clinical Project DirectorReveal Email/Phone
6
Associate DirectorReveal Email/Phone
7
Research DirectorReveal Email/Phone
8
Chief Operations OfficerReveal Email/Phone
9
Chief Medical OfficerReveal Email/Phone
10
Associate Director, Program ManagementReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is Deka BioSciences?

Deka Biosciences, Inc., is an early-stage biotechnology company focused on generating the next generation targeted cytokine therapies to treat cancer and inflammatory diseases. Deka is developing the dual cytokine, (DiakineTM) platform. Diakines are comprised of optimized, stimulatory, or suppressive disease specific IL-10 variants coupled to other stimulatory or suppressive cytokines via a T1/2 life extending tissue targeting, non-immunogenic scFv technology.

keywords:N/A

N/A

Total Funding

52

Number of Employees

$8.1M

Revenue (est)

30%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10.5M52-9%N/A
#2
$6.8M52-4%N/A
#3
$3.4M52N/AN/A
#4
$7.5M524%N/A
#5
$7M52-9%N/A